Answers are grounded in this paper and cite their sources.
The relatively slow cycle time within medicinal chemistry from synthesis to assay is constantly being challenged to help improve the efficiency of the discovery process. While both synthesis and assay have been automated to varying degrees, there has, until recently, been limited focus on the complete design, make, and test process. This Innovations article outlines the development of Cyclofluidic from inception through to the commercialization of a fully integrated closed loop design, synthesis, and screen platform.
No takes yet. Share an insight, caveat, or question.
David M. Parry (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: